Korean Medicine Patient Registry of Postoperative Therapy for Musculoskeletal Disorders (KPOP-MD): A Study Protocol

October 14, 2021 updated by: Yun-Kyung Song, Gachon University Gil Oriental Medical Hospital
To create an infrastructure that allows for the conduct of prospective, controlled studies comparing the effectiveness of diagnostic and treatment strategies for patients with musculoskeletal disorders after musculoskeletal operations

Study Overview

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Incheon, Korea, Republic of
        • Recruiting
        • Gachon universiry affiliated Gil oriental medicine hospital
        • Contact:
          • Gangmin Lee, MA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients who suffers from various symptoms after musculoskeletal surgeries

Description

Inclusion Criteria:

  • aged 19 and over
  • Those who have undergone musculoskeletal related surgery (corresponding to the disease classification code M00-99, S00-99) within 3 years
  • voluntary applicant who has no problem with communicate with study associates or a mild cognitive impairment patient who scored higher than 23 points in Korean version of the montreal rating questionnaire with voluntary participation

Exclusion Criteria:

  • Participants in other clinical trials
  • Those who are unlikely to be adhered to the schedule of clinical studies
  • Those who are expected to have difficulty understanding and responding to research questionnaires such as illiteracy, mental and physical weakness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Musculoskeletal Disorders patients
Enroll the post operative musculoskeletal disorders patients and follow up their clinic visits and treatment regimen to analyze their utility in healthcare

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in musculoskeletal pain intensity
Time Frame: At baseline, enrollment after 3/6/9/12 months
Assessment of musculoskeletal pain intensity by Numeric Rating Scale (NRS)
At baseline, enrollment after 3/6/9/12 months
Change in Disability and estimating quality of life
Time Frame: At baseline, enrollment after 3/6/9/12 months
Disability and estimating quality of life by Oswestry Disability Index
At baseline, enrollment after 3/6/9/12 months
Change in reduction of pain severity by K-WOMAC
Time Frame: At baseline, enrollment after 3/6/9/12 months
Assessment of pain severity by K-WOMAC
At baseline, enrollment after 3/6/9/12 months
Change in Pain and disability of the shoulder by SPADI questionnaire
Time Frame: At baseline, enrollment after 3/6/9/12 months
Assessment of Pain and disability of the shoulder by SPADI questionnaire
At baseline, enrollment after 3/6/9/12 months
Change in current health status
Time Frame: At baseline, enrollment after 3/6/9/12 months
The health status will be observed with the Euroqol (EQ-5D-5L) questionnaire.
At baseline, enrollment after 3/6/9/12 months
Change in Severity assessment of any symptoms other than pain
Time Frame: At baseline, enrollment after 3/6/9/12 months
Severity assessment of any symptoms other than pain by Numeric Rating Scale (NRS)
At baseline, enrollment after 3/6/9/12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2019

Primary Completion (ANTICIPATED)

May 31, 2022

Study Completion (ANTICIPATED)

May 31, 2022

Study Registration Dates

First Submitted

February 13, 2019

First Submitted That Met QC Criteria

February 13, 2019

First Posted (ACTUAL)

February 15, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 15, 2021

Last Update Submitted That Met QC Criteria

October 14, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ISEE_2018_KPOP-MD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

denial from study associates

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Disorders

3
Subscribe